Assessment of Netosis During COVID-19, Under Treatment With Anakinra, an Interleukin-1 Receptor Antagonist
CompletedOBSERVATIONAL
Enrollment
120
Participants
Timeline
Start Date
November 19, 2020
Primary Completion Date
January 31, 2021
Study Completion Date
April 26, 2023
Conditions
Covid19
Trial Locations (2)
75014
Groupe Hospitalier Paris Saint-Joseph, Paris
75018
CHU Bichat Claude Bernard, Paris
All Listed Sponsors
lead
Fondation Hôpital Saint-Joseph
OTHER
NCT04594356 - Assessment of Netosis During COVID-19, Under Treatment With Anakinra, an Interleukin-1 Receptor Antagonist | Biotech Hunter | Biotech Hunter